Logo image of MSCL.CA

SATELLOS BIOSCIENCE INC (MSCL.CA) Stock Overview

Canada - TSX-V:MSCL - CA45107J1057 - Common Stock

0.8 CAD
-0.02 (-2.44%)
Last: 10/17/2025, 7:00:00 PM

MSCL.CA Key Statistics, Chart & Performance

Key Statistics
Market Cap80.27M
Revenue(TTM)N/A
Net Income(TTM)N/A
Shares100.34M
Float78.01M
52 Week High1.32
52 Week Low0.52
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)N/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO2006-12-01
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


MSCL.CA short term performance overview.The bars show the price performance of MSCL.CA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20 30

MSCL.CA long term performance overview.The bars show the price performance of MSCL.CA in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150

The current stock price of MSCL.CA is 0.8 CAD. In the past month the price increased by 31.15%.

SATELLOS BIOSCIENCE INC / MSCL Daily stock chart

MSCL.CA Latest News, Press Relases and Analysis

2 years ago - By: Satellos Bioscience Inc. - Mentions: TSX
2 years ago - By: Satellos Bioscience Inc. - Mentions: TSX
4 years ago - By: TSX Venture Exchange
4 years ago - By: Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions

MSCL.CA Competitors/Peers

The largest stocks on the Canadian markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
EDT.CA SPECTRAL MEDICAL INC N/A 440.55M
EPRX.CA EUPRAXIA PHARMACEUTICALS INC N/A 410.87M
FRX.CA FENNEC PHARMACEUTICALS INC N/A 322.55M
HBP.CA HELIX BIOPHARMA CORP N/A 162.69M
MDNA.CA MEDICENNA THERAPEUTICS CORP N/A 75.07M
NRX.CA NUREXONE BIOLOGIC INC N/A 70.09M
COV.CA COVALON TECHNOLOGIES LTD 25.25 55.39M
MBX.CA MICROBIX BIOSYSTEMS INC N/A 35.58M
BCT.CA BRIACELL THERAPEUTICS CORP N/A 31.10M
RVX.CA RESVERLOGIX CORP N/A 30.11M
HEM.CA HEMOSTEMIX INC N/A 18.40M
CSCI.CA COSCIENS BIOPHARMA INC N/A 11.42M

About MSCL.CA

Company Profile

MSCL logo image Satellos Bioscience, Inc. is a regenerative medicine company, which engages in developing novel therapeutics. The company is headquartered in Toronto, Ontario and currently employs 3 full-time employees. The company went IPO on 2006-12-01. The firm is focused on developing medicines to treat degenerative muscle conditions. Its MyoReGenX platform is specifically designed to recreate the specialized muscle stem cell niche in vitro. MyoReGenX platform enables to map pathways which modulate muscle repair and regeneration, identify, and confirm drug targets, and test drug candidates for their ability to restore muscle stem cell repair mechanisms that have been impaired by genetic mutations, disease or injury. Its lead program is an oral, small molecule drug candidate in development as a disease-modifying treatment for Duchenne muscular dystrophy. Its iCo portfolio includes Oral Amp B Delivery System, a patented oral transport technology and Bertilimumab a human monoclonal eotaxin antibody with potential to treat a range of allergic and inflammatory conditions mediated by eotaxin-1.

Company Info

SATELLOS BIOSCIENCE INC

79 Wellington Street West, 33rd Floor

TORONTO ONTARIO CA

Employees: 3

MSCL Company Website

Phone: 16476601780

SATELLOS BIOSCIENCE INC / MSCL.CA FAQ

What is the stock price of SATELLOS BIOSCIENCE INC today?

The current stock price of MSCL.CA is 0.8 CAD. The price decreased by -2.44% in the last trading session.


What is the ticker symbol for SATELLOS BIOSCIENCE INC stock?

The exchange symbol of SATELLOS BIOSCIENCE INC is MSCL and it is listed on the TSX Venture Exchange exchange.


On which exchange is MSCL.CA stock listed?

MSCL.CA stock is listed on the TSX Venture Exchange exchange.


What is SATELLOS BIOSCIENCE INC worth?

SATELLOS BIOSCIENCE INC (MSCL.CA) has a market capitalization of 80.27M CAD. This makes MSCL.CA a Micro Cap stock.


How many employees does SATELLOS BIOSCIENCE INC have?

SATELLOS BIOSCIENCE INC (MSCL.CA) currently has 3 employees.


What are the support and resistance levels for SATELLOS BIOSCIENCE INC (MSCL.CA) stock?

SATELLOS BIOSCIENCE INC (MSCL.CA) has a support level at 0.74 and a resistance level at 0.81. Check the full technical report for a detailed analysis of MSCL.CA support and resistance levels.


Should I buy SATELLOS BIOSCIENCE INC (MSCL.CA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SATELLOS BIOSCIENCE INC (MSCL.CA) stock pay dividends?

MSCL.CA does not pay a dividend.


MSCL.CA Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to MSCL.CA. When comparing the yearly performance of all stocks, MSCL.CA turns out to be only a medium performer in the overall market: it outperformed 65.59% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

MSCL.CA Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

MSCL.CA Forecast & Estimates


Analysts
Analysts45.71
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

MSCL.CA Ownership

Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short RatioN/A